Mia's Feed
Medical News & Research

Enhancing Patient Safety: Effective Sterilization and Disinfection of Reusable Medical Devices

Enhancing Patient Safety: Effective Sterilization and Disinfection of Reusable Medical Devices

Share this article

2 min read

The Society for Healthcare Epidemiology of America (SHEA), along with eight partner organizations, has issued new comprehensive guidelines aimed at reducing infection transmission in healthcare settings through improved sterilization and high-level disinfection (HLD) of reusable medical devices. These devices are crucial in modern medicine, but improper processing can pose significant infection risks.

Persistent challenges in sterilization and HLD procedures, such as adherence to strict protocols, ambiguous manufacturer instructions, and resource limitations, continue to undermine patient safety. Notably, infections caused by multidrug-resistant organisms (MDROs) and other healthcare-associated pathogens often stem from failures in disinfecting devices like endoscopes, especially duodenoscopes, with some transmissions remaining undetected.

The new guidance, developed through an extensive review of scientific evidence and expert consensus, offers practical, evidence-based recommendations to healthcare facilities. Dr. Erica Shenoy, co-chair of the guidelines panel, emphasizes that sterilization and HLD are complex practices requiring specialized skills and resources. The guidance aims to support healthcare providers in establishing best practices to safeguard patient health.

Additionally, the guidelines suggest supplementary strategies for scenarios where sterilization or HLD may be impractical or insufficient. These include prioritizing sterilization over disinfection, utilizing single-use accessories where feasible, and reassessing the reuse of devices based on institutional capabilities.

Developed collaboratively by SHEA, the American Society for Gastrointestinal Endoscopy (ASGE), and other key organizations, the guidance encompasses newer technologies such as sterilization of investigational devices and 3D-printed implants. It also addresses common issues with manufacturer instructions that may be unclear or impractical, providing solutions for healthcare workers to implement effective processing protocols.

According to David J. Weber, co-chair of the panel, this guidance fills a critical gap by equipping healthcare professionals with adaptable, practical strategies to process medical devices safely amid evolving technologies and clinical practices.

These recommendations build upon previous guidelines and aim to enhance infection control measures, ultimately improving patient safety and reducing healthcare-associated infections.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Breakthrough Algorithm Enhances Imaging of Cardiac Tissue and Vessels

A new algorithm improves imaging of cardiac tissue and vessels, enabling earlier diagnosis and better management of cardiovascular diseases by enabling clearer visualization through existing microscopes.

Understanding Dormant Cancer Cells: How Chemotherapy Can Trigger Awakening and How Senolytic Drugs Might Prevent Relapse

New research reveals how chemotherapy can awaken dormant cancer cells, leading to relapse, and how senolytic drugs may offer a promising approach to prevent this by targeting the cellular environment that facilitates tumor reactivation.

Innovative Machine Learning Technique Advances Point-of-Care Diagnostic Testing

A groundbreaking machine learning approach enhances point-of-care biosensing, enabling faster and more accurate disease diagnostics outside traditional labs, promising broader access and improved healthcare outcomes.

Innovative Medication Shows Promise in Managing Uncontrolled Hypertension by Targeting Aldosterone Production

A new phase 3 clinical trial highlights lorundrostat, a novel aldosterone synthase inhibitor, as a promising treatment for uncontrolled and resistant hypertension, offering hope for improved management of cardiovascular risk.